Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Treatment of Parkinson's Disease With a Transdermal Skin Patch [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of a transdermal patch for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transdermal patch (Parkinson's)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED